https://www.marketscreener.com/quote/stock/ARCUTIS-BIOTHERAPEUTICS-I-101779542/news/Arcutis-Biotherapeutics-Announces-Positive-Topline-Data-from-Phase-2-Clinical-Trial-Evaluating-ARQ-31376490/?utm_source=telegram&utm_medium=social&utm_campaign=share